tiprankstipranks
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
Holding QNRX?
Track your performance easily

Quoin Pharmaceuticals (QNRX) Income Statement

267 Followers

Quoin Pharmaceuticals Income Statement

Last quarter (Q3 2024), Quoin Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Quoin Pharmaceuticals's net income was $-2.35M. See Quoin Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 9.25M$ 9.38M$ 9.26M$ 6.06M$ 1.67M$ 22.33M
Operating Income
$ -9.25M$ -9.38M$ -9.26M$ -6.06M$ -1.67M$ -22.33M
Net Non Operating Interest Income Expense
$ 196.43K$ -694.61K$ 618.34K$ -275.00K$ -47.02K$ 6.99M
Other Income Expense
$ -25.16K$ -2.68K$ 494.54K$ -12.62M$ 1.27M$ 1.47M
Pretax Income
$ -9.03M$ -8.69M$ -9.38M$ 6.29M$ -2.10M$ -16.81M
Tax Provision
-$ 79.00K$ 388.00K$ 196.00K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -8.74M$ -8.69M$ -9.45M$ -21.46M$ -2.10M$ -16.81M
Basic EPS
$ -3.92$ -9.64$ -46.80$ -1.50$ 12.00$ 0.96
Diluted EPS
$ -3.92$ -9.64$ -46.80$ -1.50$ 12.00$ 0.96
Basic Average Shares
$ 13.19M$ 900.92K$ 201.83K$ 10.57M$ 613.46K$ 17.72M
Diluted Average Shares
$ 13.19M$ 900.92K$ 201.83K$ 10.57M$ 613.46K$ 17.72M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 9.25M$ 9.38M$ 9.26M$ 6.06M$ 1.67M$ 22.33M
Net Income From Continuing And Discontinued Operation
$ -8.58M$ -8.69M$ -9.38M$ -21.46M$ -2.10M$ -16.81M
Normalized Income
$ -8.55M$ -6.84M----
Interest Expense
------
EBIT
$ -8.72M$ -10.00M$ -8.67M$ -20.37M$ -2.05M$ -16.81M
EBITDA
$ -8.61M$ -9.89M$ -8.56M$ -20.27M$ -1.94M$ -16.43M
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis